Pinealon
The short answer. There isn't much data on Pinealon yet — 44 mentions, 10 with a clear outcome — so treat these numbers as anecdotal. It is most often used for sleep: 100% of 5 reports say that improved. We found no human trials on PubMed. It is not an approved supplement and carries real risks.
From 44 mentions in total — the rest didn't say how it went and aren't counted.
What Pinealon does, according to users
Of the people who reported each effect, the share who said it got better.
2 more with fewer than 3 reports
What the research says
Systematic reviews and meta-analyses from PubMed, with their published conclusions.
No randomized controlled trials in humans found on PubMed. The grade measures how much human research exists — read the conclusions below for what it found. 0 meta-analyses on PubMed ↗ · 0 randomized trials ↗
Dosage people report
Reported side effects
How often each side effect came up across all reports.
What users say
First-hand experiences, quoted verbatim. We show one positive and one negative where both exist.
“No peptide has done as much for me as Pinealon. I feel like it shook a decade's worth of cobwebs loose from my brain.”
“If you will do injectable peptides my absolute favorite is Pinealon (it is actually a peptide bioregulator). You can get it in a capsule too but the injectable works better in my experience.”
“I run them in cycles every 6 months with SS-31 in between, all to improve mitochondria health and function; and largely to help with sleep improvement.”
“Pinealon gave me the best sleep of my life! It resets your circadian rhythm.”
Pinealon compared
Other options for sleep
Sources
- User reports: 44 mentions in public discussions, quoted with a link to each discussion (e.g. this thread ↗).
- PubMed (US National Library of Medicine, NIH): meta-analyses ↗ · randomized trials ↗
User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 5, 2026. How we rate